Research Article
Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma
Table 3
Multivariate analysis of overall survival.
| Factors | Levels | Beta | value | HR | 95% CI |
| Gender | Male versus female | −0.107 | 0.679 | 0.898 | 0.54 to 1.493 | Tumor length | 5 versus <5 | −0.038 | 0.870 | 0.963 | 0.614 to 1.51 | Age | 65 versus <65 | 0.274 | 2.610 | 1.316 | 0.815 to 2.124 | T category | T1 + T2 versus T3 + T4 | 1.406 | 0.006 | 4.081 | 1.489 to 11.183 | N category | N0 versus N1 | 2.930 | 0.000 | 18.728 | 4.084 to 85.878 |
p-stage | I versus II + III | −1.771 | 0.047 | 0.170 | 0.03 to 0.978 | Differentiation | Well versus moderate + poor | 1.756 | 0.001 | 5.790 | 2.033 to 16.491 | mTOR | High versus low | 0.710 | 0.020 | 2.033 | 1.117 to 3.701 |
|
|
HR: hazard ratio; CI: confidence interval.
|